Skip to content

Resistance Exercise Volume and Hypertrophic Response Variability in Elderly

Effects of Resistance Exercise Volume on the Variability of the Hypertrophic Response in Elderly

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06718712
Enrollment
102
Registered
2024-12-05
Start date
2018-04-01
Completion date
2018-12-20
Last updated
2024-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Muscle Hypertrophy

Keywords

aging, muscle mass, muscle strength, resistance exercise, sets

Brief summary

The study aimed to investigate the effects of resistance training volume manipulation on whole muscle hypertrophy among non-responders and responders to a low resistance training dose (single-set).

Detailed description

The magnitude of muscle hypertrophy in response to resistance training (RT) is highly variable between individuals (response heterogeneity). Manipulations in RT variables may modulate RT-related response heterogeneity; yet, this remains to be determined.

Interventions

The RT protocol was performed using a unilateral knee-extension machine. To reduce potential sources of bias to exercise order, subjects alternated the starting leg for each training session.

Sponsors

University of Sao Paulo
CollaboratorOTHER
University of Sao Paulo General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Lower body unilateral design

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 60 years and older * not engaged in regular resistance and/or aerobic training for at least six months before the intervention

Exclusion criteria

* diagnosed type I diabetes mellitus * arrhythmia * noncontrolled hypertension * any major orthopedic musculoskeletal condition * use of any dietary supplement or drug with potential anabolic effects

Design outcomes

Primary

MeasureTime frameDescription
Quadriceps muscle cross-sectional area10 weeksQuadriceps muscle CSA was obtained through magnetic resonance imaging.

Secondary

MeasureTime frameDescription
Maximum dynamic strength10 weeksUnilateral quadriceps 1-RM of both legs were assessed on a knee-extension machine

Other

MeasureTime frameDescription
Skeletal muscle RNA-sequencing10 weeksRNA sequencing using an Illumina NovaSeq Platform with a standard paired-end 150 bp (PE150) dual indexing protocol
Dietary assessmentBefore interventionDietary assemment using the USDA Automated Multiple-Pass Method
Mass spectrometry10 weeksMass spectrometry metabolomics
Muscle protein measures10 weeksUpstream binding factor (UBF) muscle protein was quantified by Simple Western capillary immunoassay.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026